Posts in: press clippings

Grow Everything podcast featuring Damien Perriman
press releasenutraceuticalsmedicinepress clippingsscience
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcastApril 10, 2026
The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
nutraceuticalspress clippings
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss DrugsApril 9, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideo
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
NLR: Why Use Living Cells?
biofuelmedicinepress clippingsscience
NLR: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneMarch 26, 2026
SynBioBeta: Successful pilot scale run
press clippings
SynBioBeta: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 21, 2026
Business Insider
press clippings
Business Insider: eXoZymes announces validation milestone for its biomanufacturing platformMarch 20, 2026
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and Scalability
press clippings
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and ScalabilityMarch 20, 2026
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
press clippings
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman ChemicalMarch 19, 2026
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026
investorpress clippingsvideo
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026February 16, 2026
Nasdaq's 'Amplify Spotlight'
heltzeninvestorpress clippingsvideo
Nasdaq: Michael B. Spector interviews CEO HeltzenFebruary 5, 2026
Previous page
Page 1 of 4
Next page